SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-082619
Filing Date
2013-11-08
Accepted
2013-11-08 09:47:46
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19516_110q.htm 10-Q 918866
2 EX-31.1 a13-19516_1ex31d1.htm EX-31.1 12621
3 EX-31.2 a13-19516_1ex31d2.htm EX-31.2 12709
4 EX-32.1 a13-19516_1ex32d1.htm EX-32.1 7832
  Complete submission text file 0001104659-13-082619.txt   6668867

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cldx-20130930.xml EX-101.INS 787525
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20130930.xsd EX-101.SCH 73287
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20130930_cal.xml EX-101.CAL 71827
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20130930_lab.xml EX-101.LAB 1165951
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20130930_pre.xml EX-101.PRE 533389
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20130930_def.xml EX-101.DEF 314470
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 131202796
SIC: 2835 In Vitro & In Vivo Diagnostic Substances